Ati cautat: v

Protocol terapeutic: L016C – : DCI INTERFERON ALFA 2B (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L015D – DCI ANAGRELIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L014C – DCI RITUXIMABUM (original şi biosimilar) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L012C – DCI BORTEZOMIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L008C – DCI IMATINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L002G – DCI TRATAMENT IMUNOMODULATOR – SCLEROZĂ MULTIPLĂ (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)

Protocol terapeutic: L001G – DCI MITOXANTRONUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: J010D – DCI : CASPOFUNGINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: J007N – DCI INTERFERONUM ALFA 2A (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: J006N – DCI INTERFERONUM ALFA 2B (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)